Cibus, Inc. (NASDAQ:CBUS) Q1 2024 Results Conference Call May 9, 2024 4:30 PM ET Company Participants Wade King - Chief Financial Officer Rory Riggs - Co-Founder, Chief Executive Officer and Chairman Peter Beetham - Co-Founder, President and Chief Operating Officer Conference Call Participants Bobby Burleson - Canaccord Genuity Carol Cheung - Jefferies Steve Byrne - Bank of America Operator Good afternoon, and welcome to the Cibus First Quarter 2024 Results Conference Call. [Operator Instructions] Please al ...

Cibus (CBUS) came out with a quarterly loss of $1.12 per share versus the Zacks Consensus Estimate of a loss of $1.01. This compares to loss of $5.45 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -10.89%. A quarter ago, it was expected that this developer and licensor of plant traits for seed companies would post a loss of $1.12 per share when it actually produced a loss of $1.16, delivering a surprise of -3.57%.Over the las ...

_____________________ FORM 10-Q or Commission file number 001-38161 Securities registered pursuant to Section 12(b) of the Act. Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o If an emerging growth company, indicate by check mark if the reg ...

Important EU Parliament vote on gene editing continues global momentum for the approval of new genomic techniques (NGTs) as similar to conventional breeding Completed single cell regeneration platform for Wheat – with Canola & Rice, Cibus now has its semiautomated crop platform operational for 3 of the top 5 major crops Continued progress with customers toward commercializing Pod Shatter Reduction (PSR) trait in Canola Cibus was recognized by Fast Company as one of the world's most innovative companies of 2 ...

SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2024 financial results on Thursday, May 9, 2024. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: C ...

Cibus (CBUS) came out with a quarterly loss of $1.16 per share versus the Zacks Consensus Estimate of a loss of $1.12. This compares to loss of $3 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -3.57%. A quarter ago, it was expected that this genetically modified food company would post a loss of $1.18 per share when it actually produced a loss of $1.59, delivering a surprise of -34.75%.Over the last four quarters, the compan ...

Cibus, Inc. (NASDAQ:CBUS) Q4 2023 Results Conference Call March 21, 2024 4:30 PM ET Company Participants Wade King - Chief Financial Officer Rory Riggs - Co-Founder, Chief Executive Officer and Chairman Peter Beetham - Co-Founder, President and Chief Operating Officer Conference Call Participants Bobby Burleson - Canaccord Genuity Sameer Joshi - H.C. Wainwright Operator Good afternoon, and welcome to the Cibus Fourth Quarter 2023 Results Conference Call. All participants will be in a listen only mode. After ...

Cibus is currently in the process of developing an RTDS platform for Soybean. Its soybean single-cell regeneration platform is now expected to be operational, and have initial editing completed, in 2024. | --- | --- | --- | --- | --- | --- | --- | |-------------------------|------------------------|---------------------------|-------------------------------------------------|------------------------------------|--------------------------------------------|---------------------------------------------------- ...

• Opened Dedicated, High-throughput Gene Editing Facility for Trait Production ◦ Supports vision to change the precision, speed, and scale, and range of Cibus' growing RTDS crop and trait development pipeline ◦ Represents the industry's first semi-automated gene editing trait production system that provides a timebound, predictable, and reproducible breeding system for the editing of commercial plants • Raised $20.3 million of gross proceeds in December 2023 ◦ Cibus intends to use the net proceeds to fund f ...

SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that it has been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2024, ranking as the 2nd most innovative company in the agriculture category. This year's list shines a spotlight on businesses that are shaping industry an ...